Early cardiovascular manifestations in children and adolescents with autosomal dominant polycystic kidney disease: a single center study

被引:15
|
作者
Karava, Vasiliki [1 ]
Benzouid, Cherine [2 ]
Hogan, Julien [1 ]
Dossier, Claire [1 ]
Denjean, Andre Pierre [2 ]
Deschenes, Georges [1 ]
机构
[1] Robert Debre Hosp, AP HP, Pediat Nephrol Dept, Paris, France
[2] Robert Debre Hosp, AP HP, Pediat Cardiol Dept, Paris, France
关键词
ADPKD; Arterial stiffness; Cardiovascular; Gene mutation; Pediatrics; Renal function; INTIMA-MEDIA THICKNESS; PULSE-WAVE VELOCITY; ARTERIAL STIFFNESS; BLOOD-PRESSURE; VASCULAR CHANGES; REFERENCE VALUES; HYPERTENSION; METAANALYSIS; ASSOCIATION; DYSFUNCTION;
D O I
10.1007/s00467-018-3964-9
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
This study aims to describe the cardiovascular manifestations in children with autosomal dominant polycystic kidney disease (ADPKD) and detect their relation with kidney disease and type of gene mutation. Twenty-one patients (7 to 19 years old) were included. Cardiovascular evaluation involved blood pressure (BP), indexed left ventricular mass (LVMI), pulse wave velocity (PWV), and carotid intima media thickness (cIMT) measurement. Patients were classified according to percentile reference values of these parameters in healthy children. The 95th percentile was the highest level of normal values. Glomerular filtration rate (GFR) and microalbuminuria were also measured. Antihypertensive treatment, large LVMI, high PWV, and increased cIMT were observed in 6 (28.6%), 2 (9.5%), 4 (19%), and 8 (38.1%) patients respectively. Antihypertensive treatment was not associated with either high PWV or increased cIMT. Linear correlation was noticed between LVMI and PWV (r (2) = 0.243, p = 0.023) and also between LVMI and cIMT (r (2) = 0.203, p = 0.041). The median age of patients with high PWV, increased cIMT, and large LVMI was 9.5, 13, and 18 years old. GFR was normal in all patients. Patients with increased cIMT presented higher levels of urine microalbumin to creatinine ratio (p = 0.025). Genetic mutation was available in 18 patients. Antihypertensive treatment was more frequent in patients without PKD1 missense mutation (p = 0.044). High PWV and increased cIMT indicating arterial stiffness and hypertrophic vasculopathy may be present in children with ADPKD regardless BP status, and prior to GFR decline, suggesting that vascular disease precedes chronic kidney disease in ADPKD.
引用
收藏
页码:1513 / 1521
页数:9
相关论文
共 50 条
  • [41] Hypertension and Cardiovascular Problems in Autosomal Dominant Polycystic Kidney Disease
    Ecder, Tevfik
    TURKISH NEPHROLOGY DIALYSIS AND TRANSPLANTATION JOURNAL, 2007, 16 : 22 - 26
  • [42] Cardiovascular abnormalities in autosomal-dominant polycystic kidney disease
    Tevfik Ecder
    Robert W. Schrier
    Nature Reviews Nephrology, 2009, 5 : 221 - 228
  • [43] Cardiovascular abnormalities in autosomal-dominant polycystic kidney disease
    Ecder, Tevfik
    Schrier, Robert W.
    NATURE REVIEWS NEPHROLOGY, 2009, 5 (04) : 221 - 228
  • [44] Autosomal Dominant Polycystic Kidney Disease in Children and Adolescents: Assessing and Managing Risk of Progression
    Dachy, Angoelique
    Van Loo, Liselotte
    Mekahli, Djalila
    ADVANCES IN KIDNEY DISEASE AND HEALTH, 2023, 30 (03): : 236 - 244
  • [45] Tolvaptan for Children and Adolescents with Autosomal Dominant Polycystic Kidney Disease Randomized Controlled Trial
    Mekahli, Djalila
    Guay-Woodford, Lisa M.
    Cadnapaphornchai, Melissa A.
    Greenbaum, Larry A.
    Litwin, Mieczyslaw
    Seeman, Tomas
    Dandurand, Ann
    Shi, Lily
    Sikes, Kimberly
    Shoaf, Susan E.
    Schaefer, Franz
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2023, 18 (01): : 36 - 46
  • [46] CARDIOVASCULAR-ABNORMALITIES IN CHILDREN WITH AUTOSOMAL-DOMINANT POLYCYSTIC KIDNEY-DISEASE
    IVY, DD
    SHAFFER, EM
    JOHNSON, AM
    KIMBERLING, WJ
    DOBIN, A
    GABOW, PA
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1995, 5 (12): : 2032 - 2036
  • [47] The influence of renal manifestations to the progression of autosomal dominant polycystic kidney disease
    Idrizi, A.
    Barbullushi, M.
    Petrela, E.
    Kodra, S.
    Koroshi, A.
    Thereska, N.
    HIPPOKRATIA, 2009, 13 (03) : 161 - 164
  • [48] DNA diagnosis and clinical manifestations of autosomal dominant polycystic kidney disease
    Merta, M
    Stekrova, J
    Zidovska, J
    Vorsilkova, M
    Walterova, J
    Kapras, J
    Alanova, M
    Raskova, D
    Rysava, R
    FOLIA BIOLOGICA, 1997, 43 (05) : 201 - 204
  • [49] Polycystic Kidney Disease-Related Disease Burden in Adolescents With Autosomal Dominant Polycystic Kidney Disease: An International Qualitative Study
    Oberdhan, Dorothee
    Schaefer, Franz
    Cole, Jason C.
    Palsgrove, Andrew C.
    Dandurand, Ann
    Guay-Woodford, Lisa
    KIDNEY MEDICINE, 2022, 4 (03)
  • [50] Deceased Donor Kidney Transplantation in Autosomal Dominant Polycystic Kidney Disease: A Single-Center Experience
    Kute, Vivek B.
    Shah, Pankaj R.
    Goplani, Kamal R.
    Gumber, Manoj R.
    Vanikar, Aruna V.
    Patel, Himanshu V.
    Jain, Siddharth H.
    Enginner, Divyesh P.
    Trivedi, Hargovind L.
    SAUDI JOURNAL OF KIDNEY DISEASES AND TRANSPLANTATION, 2011, 22 (05) : 911 - 916